GPRC5D-Targeted CAR T Cells for Myeloma

Overview of attention for article published in New England Journal of Medicine, September 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

news: 33 news outlets
blogs: 4 blogs
twitter: 133 X users
patent: 20 patents

facebook: 1 Facebook page
guideline: 2 clinical guideline sources
podcasts: 2 podcasts

Readers on

mendeley: 229 Mendeley

So far, Altmetric has seen 40 news stories from 33 outlets.

Advances in CAR T-Cell Therapy for Multiple Myeloma

MedPage Today, 31 May 2024

Spotlight On > ASCO: Multiple Myeloma As approved products move to earlier use, novel approaches aim to improve responses after…

Practical Considerations of T-Cell Engagers in the Management of Relapsed/Refractory Multiple Myeloma

Pharmacy Times, 21 Apr 2024

Précis Integration of these agents requires supportive care considerations for cytokine release syndrome, neurotoxicity…

MSK Research Highlights, November 27, 2023

EurekAlert!, 27 Nov 2023

image: MSK researchers view more Credit: Memorial Sloan Kettering Cancer Center New research from Memorial Sloan Kettering…

Episode 5: CAR T-Cell Therapy for Multiple Myeloma

Medscape, 10 Aug 2023

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 36 additional news stories.